Sunny Uberoi

Uberoi joined Aditxt to raise the company's profile in advance of initiating its first-in-human clinical trials and support the rapid scaling of AditxtScore, a commercial technology platform designed to provide a personalized, comprehensive profile of the immune system. In this new role, Uberoi is responsible for leading global corporate communications, investor relations, and government affairs.

Most recently, Uberoi served as the Vice President of Corporate Affairs for Global Drug Development, Research and Early Development, and Global Product Supply at Bristol Myers Squibb. Uberoi also led communications for S&P Global Market Intelligence, including the asset divesture of J.D. Power. Before that, he was the Head of Corporate Stakeholder Engagement at Deloitte as well as the Head of Global Communications for Consumer Health at Pfizer.

Uberoi earned his bachelor's degree in Economics from The Manchester Metropolitan University and a Master's degree in Marketing from The University of Manchester.